Skip to content

Sevens Elise

Active
Private limited companyfounded 2022active for 4 yearsSlekkebeek 46, 9230 Wetteren, BelgiumKBO/BCE: BE 0789.573.763
Summary

Sevens Elise has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €3,250 and a net result of €50,250. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 23% of 444 sector peers (NACE 47, financial year 2026). The computed 12-month bankruptcy probability is 0.7% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€53,817total assets 2026
Equity
€3,250
Profit
€50,250
Turnover not published (micro format)
Financial health
69 Healthy Checked score 2026
Bankruptcy probabilitywithin 12 months
0.7%
Structure
Accounts 44 days early0 of 1 deed read
Why 69raises riskFounded in 2022Equity €3,250 (6.0% of total assets)lowers riskLiquidity: current ratio 1.06, cash €40,444, halvedSize: total assets €53,817Show the evidence

Checked score

Score 2026
69 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 44% of its sector peers (NACE 47, micro)
Financial strength · tick = 2025
Strong
Solvency 31-69
equity 6.0% of total assets
Liquidity 50-48
short-term debt 94.0% · cash 75.2%
Profitability 100=
return on assets 93.4%
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,226 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.1%▼ -0.1 percentage points vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026lowest value 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.7%▲ +0.6 percentage points vs 09-2026highest value
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 23% on solvency, 52% on liquidity, 96% on profitability and 6% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 1.06, cash €40,444, halved
NBB · annual accounts
raises risk · Founded in 2022
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Equity €3,250 (6.0% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €53,817
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 444 sector peers (2026).
NBB · sector comparison
Position among 444 sector peers
Solvency
better than 23%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 17-09-2026, 44 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2026
44 days early
2025
17 days early
2024
1 day early
2023
4 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 17 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 21 October (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2022.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Highest result from 2023 to 2026net €50,250 ▲18.9%
  3. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Caution: Equity fell in 2026from €110,548 to €3,250 ▼ 97.1% View
  • Positive: Among the best 16% on net resultsector median €7,450 · 443 companies €50,250 View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View

By topic

Financials

Financial year
2026
Total assets
€53,817
Profit
€50,250
Solvency
6.0%
Total assets▼ 58.1%
Net result
20232026
Go to Financials

Timeline

Events
6
Since
2023
Next accounts
by 31-10-2027
  1. 31-03-2025Equity above €100,000
  2. 30-10-2024Annual accounts filed
  3. 27-10-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
11-08-2022
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.